Business Context and Reporting Period
Vyome Holdings, Inc. (formerly ReShape Lifesciences Inc.) filed a Form 8-K on August 18, 2025, reporting events occurring on August 18 and August 20, 2025. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Cambridge, MA.
Key Financial Metrics
This filing is a Current Report (Form 8-K) and does not contain periodic financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Equity Distribution Agreement Amendment: On August 20, 2025, the Company amended its Equity Distribution Agreement with Maxim Group LLC. The maximum amount of common stock available for sale in the at-the-market offering was increased from $3,420,926 to $12,000,000.
- Change in Certifying Accountant: On August 18, 2025, the Company dismissed Haskell & White LLP and appointed Kreit & Chiu CPA LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025.
Outlook, Risks, and Contingencies
- Going Concern: The filing notes that the predecessor auditor's report for the fiscal year ended December 31, 2024, contained an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
- Internal Controls: The Company reported material weaknesses in its internal control over financial reporting as of December 31, 2024.
- Auditor Disagreements: The Company stated there were no disagreements with the former auditor regarding accounting principles, practices, or audit scope during the relevant periods, aside from the aforementioned going concern and internal control matters.
Investor Verification Checklist
- Verify the terms and execution status of the amended Equity Distribution Agreement (Exhibit 1.1) to confirm the $12,000,000 offering capacity.
- Review the Company's most recent Form 10-K or 10-Q to assess the current status of the "substantial doubt" regarding going concern and the remediation of material weaknesses in internal controls.
- Confirm the transition timeline and scope of work for the new auditor, Kreit & Chiu CPA LLP.
- Monitor future filings for actual proceeds generated from the at-the-market offering.